Looking at Leukemias- Acute Myeloid Leukemia

Up until recently, Acute Myeloid Leukemia (AML) had essentially been treated the same way for decades but in the last few years new therapies and treatment approaches have been approved for use by the FDA and many promising therapies are being tested in clinical trials. In this episode, we take a look at this cancer and these recent developments with one of the nation’s foremost experts on blood cancers, and a returning guest to the show, Dr. Thomas LeBlanc.